Aurora Capital is both a boutique investment banking firm specializing in the life sciences sector and a full service brokerage firm. Our LifeTech Capital Research Division writes unique and proprietary equity research covering biotechnology and other life science companies. Our Hedge Fund and Direct Participation Program Group is currently in formation and will raise funds for hedge funds, fund of funds and direct participation programs.

Ushering in a New Era in Life Sciences Investment Banking.

Aurora Capital is comprised of an experienced team of professionals specializing in the sector, which utilizes a rigorous process in the selection of investment ideas and investment banking clients. In addition to in-house expertise and experienced personnel, Aurora retains the services of a network of qualified scientific advisors and consultants.

Aurora’s Investment Banking Division is comprised of four groups: (i) the Capital Markets Group; (ii) the India Group; (iii) the China Group; and (iv) the LifeTech Capital – Investment Banking Division. All four groups provide their uniquely focused services that include: (a) serving as a placement agent in private placement securities offerings by public and private companies which offerings are exempt from registration under various federal and state laws and the rules and regulations promulgated under such laws; and (b) providing a variety of consulting and advisory services to our corporate finance clients.

The LifeTech Capital Investment Banking Division acts as an independent subdivision of Aurora Capital, focusing on providing PIPE, overnight, and registered direct finance opportunities to the firm's corporate finance clients.

Please visit the Management Letter page to view Aurora Capital's latest press releases.

Ushering in a New Era in Life Sciences Equity Research.

The LifeTech Capital Research Division writes unique and proprietary equity research available to the public.

Full Service Brokerage.

Our Public Securities Brokerage Division offers service brokerage transaction capabilities, and clearing public securities transactions through Legent Clearing LLC in Omaha, Nebraska.

Hedge Fund and Direct Participation Program Group.

This Group is currently in formation.

Please visit the Management Letter page to view Aurora Capital's latest press releases.

Since 1995, Aurora Capital LLC has been registered as a broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following:

Financial Industry Regulatory Authority (FINRA) (formerly NASD)
Municipal Securities Rule Making Board (MSRB)
Securities Insurance Protection Corporation (SIPC)

Aurora's enduring objective is attempting to achieve equitable valuations for our investment banking clients while concurrently providing investor returns commensurate with the risks inherent in emerging technologies.

Our mission is to provide valuable or undiscovered investment opportunities to our investing clients. These opportunities may arise from any of our four divisions: Life Sciences Investment Banking, Life Sciences Research, Public Securities Brokerage, or our Hedge Fund and Direct Participation Program Group. We seek to provide high quality service to a corporate finance client base which may be overlooked or underserved by the major and regional investment banking organizations primarily due to company or transaction size.

Powered by